revns

What causes recurrent miscarriage? A 2026 genome study found genes in about 1 in 4 families tested

Genome Medicine sequenced 118 families with normal-chromosome losses; plausible gene variants in 30. What it means, limits, and exercise while you wait.

revns editorial · Published November 17, 2026 · 9 min read

Genome Medicine study of 118 families: trio sequencing found plausible monogenic causes in 30 families, mostly inherited. Expands testing ideas but does not change day-to-day exercise rules yet.

Repeated miscarriage with normal chromosome tests still often has no clear cause — but a November 2026 study in Genome Medicine found plausible single-gene explanations in 30 of 118 families who fit that pattern. Researchers sequenced both parents and the miscarriage tissue (a "trio" design), which is stronger than testing tissue alone. Pathogenic or likely pathogenic variants showed up in 18 families (15.3%), and variants of uncertain significance in 12 families (10.2%). Stanford Medicine, which co-led the work, stresses that most findings were inherited from healthy parents and that uncertain variants must not drive IVF or treatment choices yet. If you searched what causes recurrent miscarriage, this paper adds evidence — it does not prove your last loss was "because of the gym."

TL;DR

FactDetail (Genome Medicine 2026, Stanford Medicine release)
Population118 families with unexplained, chromosomally normal recurrent pregnancy loss after standard exclusions
DesignWhole-genome sequencing of parents + miscarriage tissue ("trio")
Clear gene findings18 families (15.3%) with pathogenic/likely pathogenic variants
Uncertain gene findings12 families (10.2%) with variants of uncertain significance
Inherited patternVariants in candidate genes inherited in 80% of families with plausible findings; 24 of 30 families had a parent carrier, often asymptomatic (Stanford release)
UltrasoundAbout 95% had no major structural anomaly before loss (Stanford release)
TimingAbout 79% of losses in the first trimester (Stanford release)
Reader takeawayResearch supports expanding genetics in specialist RPL work; does not change home exercise rules overnight
Weekly plan concept illustration beside a guide on waiting for medical tests
While clinics investigate, steady sleep, food and gentle movement beat guessing.

What is recurrent miscarriage?

Recurrent pregnancy loss (RPL) means more than one pregnancy loss before viability. The Stanford Medicine release tied to this study defines it as two or more miscarriages and estimates it affects about 5% of couples.

Definitions used in clinics can differ by country. The NHS often discusses referral pathways after three consecutive miscarriages, while some programmes investigate sooner, especially with maternal age or prior normal test results. If you are unsure which threshold applies to you, ask your GP or early pregnancy unit rather than counting from a blog.

Roughly 70% of recurrent loss cases have a chromosomally normal embryo or fetus on standard testing, according to the Stanford release — yet many of those still lack an explanation after karyotype and chromosomal microarray. That is the gap this genome study targets.

This is emotionally heavy territory. Repeated loss is not caused by being "too fit" or "not fit enough" in any single study we cite here. Grief is real. If you feel hopeless or have thoughts of self-harm, contact a clinician or a crisis line in your country immediately. In the UK, Samaritans are on 116 123 (free, 24 hours). An app does not treat miscarriage or diagnose infertility.

What did the genome sequencing study do?

The peer-reviewed paper "Genetic variants in recurrent euploid pregnancy loss" by Mona Aminbeidokhti and colleagues appeared in Genome Medicine on 16 November 2026 (open access). Collaborators included Stanford Medicine, UC San Francisco, Oregon Health & Science University, University of Illinois Chicago and Natera, with NIH grant R01 HD105256.

Between 2022 and 2024, investigators enrolled 176 families with unexplained recurrent loss. After excluding losses with chromosome abnormalities or DNA too poor to sequence, 118 families remained for analysis. About 95% lacked major fetal structural anomalies on ultrasound before the loss, per Stanford's summary.

For each family, the team ran whole-genome sequencing on both parents and miscarriage tissue. Older miscarriage genetics papers often sequenced only the pregnancy, which makes it hard to tell inherited variants from new embryo changes or from harmless background noise. The trio design is the methodological advance this paper emphasises.

They then filtered rare variants (allele frequency ≤ 0.1% in population databases) through a tiered pipeline: genes linked to lethal newborn conditions, developmental essentiality, fetal gene expression timing, and orthogonal confirmation where possible.

What causes recurrent miscarriage in this cohort?

The study separates clearer genetic hits from suggestive but unproven ones.

Pathogenic and likely pathogenic variants (18 families, 15.3%)

The paper reports pathogenic/likely pathogenic variants in 18 families across 17 genes. Patterns included:

  • Biallelic damage (two damaged copies) in genes such as DHCR7, PIEZO1, PIGV, PRF1, SLC12A3 and SMN1 — the classic "both parents carried one copy, embryo inherited both" model seen in 11 families in Stanford's plain-language summary.
  • X-linked variants in male pregnancies with no second X to compensate (five families in the Stanford release narrative).
  • Dominant heterozygous variants, some de novo, in genes such as EFTUD2, HNRNPK, FGFR2 and KAT6A.
  • Parental mosaicism (variant in only some egg or sperm cells) in FGFR2 and PORCN in the paper's results section.

Stanford highlights DHCR7 in one family: both parents carried a damaged copy; babies with two damaged copies can have Smith-Lemli-Opitz syndrome, but the disorder is rarer at birth than carrier rates predict, a gap clinicians have long suspected reflects early pregnancy loss. This family's 12-week loss fits that hypothesis — still one case, not proof for everyone.

Variants of uncertain significance (12 families, 10.2%)

Another 12 families carried variants labelled of uncertain significance in genes involved in development (the paper lists genes such as ABCB7, CLPB, FBN1, FLT4, GJA1 and others). The evidence is suggestive, not established as a miscarriage cause.

What the study cannot show

  • Not every loss in a family shared the variant. Stanford notes that in three families, additional miscarriage samples did not carry the flagged variant — other mechanisms may still apply.
  • 108 of 118 families had tissue from only one loss for sequencing, limiting proof that the same variant recurred across multiple pregnancies.
  • Mouse models and gene expression timing support biology, but researchers cannot experimentally provoke miscarriage in humans. Association is not automatic causation.
  • Findings apply to families who already entered a research genetics programme, not a random sample of everyone who trains and miscarries once.

How common are genetic findings in recurrent miscarriage?

Simple arithmetic from this single study: 30 of 118 families (25.4%) had plausible variants when you combine pathogenic/likely pathogenic and uncertain-significance groups. The actionable pathogenic/likely pathogenic rate is 15.3%.

You may see headlines round that to "about one in four families." That is this cohort's yield, not a guarantee your clinic will find a gene. Yields will change as tests move from research to NHS or US healthcare pathways, insurance rules, and laboratory standards.

The paper also reports four families (3.4%) with biallelic ultra-rare variants in developmental pathway genes not yet linked to human disease — interesting for science, not ready for patient decisions.

What changes for testing and treatment?

What researchers propose

Authors argue that trio genome sequencing could supplement karyotype and chromosomal microarray in specialist recurrent-loss work. A confirmed pathogenic variant might improve recurrence-risk counselling and, in the future, embryo testing in IVF for known variants — ideas Stanford discusses explicitly.

They also draw a parallel to preconception carrier screening for severe childhood disorders, extending the concept to miscarriage risk. That is a research direction, not a new NHS blanket programme as of November 2026.

What they say you must not do yet

The Stanford release and paper conclusions repeat a caution: variants of uncertain significance and newly proposed genes should not guide embryo selection, pregnancy termination decisions, or other medical choices until more families confirm the link.

The team is enrolling additional families to validate the 28 implicated genes (15 novel to pregnancy loss in this paper, 13 previously tied to perinatal death).

What does not change today

  • Moderate exercise when pregnant and medically cleared still aligns with exercise in pregnancy guidance from WHO, NHS and CDC — this genetics paper does not revise those activity targets.
  • No supplement, hormone or "fertility stack" appears in the trial. We do not discuss drugs as fixes for miscarriage.
  • revns does not run genetic tests, read miscarriage tissue, or replace a recurrent-pregnancy-loss clinic. You can log mood, sleep and training for your own conversations with clinicians; that is not diagnosis.

Does exercise cause recurrent miscarriage?

There is no evidence in this paper that training caused these losses. The cohort was selected for unexplained euploid recurrence after specialist work-up, not for gym habits.

Broader literature (not replaced by this study) generally finds moderate physical activity is not a usual cause of miscarriage in uncomplicated pregnancies, per WHO and CDC summaries in our pregnancy guide. Extreme energy deficit, uncontrolled illness, or contraindicated sport when pregnant are separate conversations with your team.

After a loss:

  • Rest until your clinician clears you, especially if you had surgery or heavy bleeding.
  • Return with walking, mobility and light strength if you feel ready — not because it prevents the next loss, but because movement, sleep and routine support mental health for many people.
  • High-impact or heavy barbell work while actively bleeding or during a new pregnancy needs individual clearance.

If you track your period and cycle, dates help you show clinicians bleeding patterns. Apps cannot detect pregnancy viability.

Coaching concept art showing rest and rebuilding after hard training blocks
Recovery weeks after loss look different from a deload week — follow clinical advice first.

What is recurrent miscarriage testing today?

Standard pathways (country-specific) often include:

  • History and blood tests for thyroid, diabetes, coeliac disease and clotting disorders where indicated.
  • Pelvic ultrasound for uterine shape or fibroids.
  • Parental karyotype in some services.
  • Products of conception testing after a loss to check chromosome balance.

This study argues for eventually adding trio whole-genome or exome sequencing in selected unexplained euploid cases. Availability, cost and insurance vary; Stanford does not claim the test is ready for every GP surgery.

If you are offered research sequencing, ask:

  • Who sees results?
  • How are variants of uncertain significance handled?
  • Does the lab share data for family planning only with a genetics counsellor?

What to do this week while you wait for answers

These steps are general habits, not a miscarriage treatment plan.

  1. Book or attend follow-up your early pregnancy unit or GP arranged. Bring a list of loss dates and any pathology reports.
  2. Eat regularly: lentils, beans, tofu, eggs or lean meat for protein; leafy greens and fortified cereals if iron is low — only change iron supplements on lab advice.
  3. Sleep: aim for a steady wake time; see sleep and mood if nights are fractured by grief.
  4. Movement: if cleared, 20–30 minutes of easy walking most days beats sitting in guilt. Skip maximal lifts until you feel physically recovered.
  5. Support: tell one person the truth. Peer support groups and bereavement counselling exist in many countries; ask your GP.
Blue sleep-cycle ring concept image supporting a section on rest during medical waiting periods
Short sleep and high stress are common after loss — tracking can show your clinic trends, not causes.

When to see a professional (red flags)

Seek urgent care for:

  • Heavy bleeding (soaking pads quickly), severe pain, fever, faintness, or shoulder-tip pain (possible ectopic pregnancy — emergency).
  • Signs of infection after surgical management of miscarriage.
  • Thoughts of harming yourself or inability to function — crisis services or A&E.

Book non-urgent but prompt review if:

  • You have two or more losses and no referral yet.
  • Periods do not return within 6–8 weeks after loss (individual timing varies).
  • You want preconception advice before trying again, especially over age 35 or with known conditions.

This is general training guidance, not medical advice. It does not diagnose recurrent pregnancy loss, interpret genetic tests, or recommend IVF strategies. Decisions belong with your obstetrician, GP, genetics service or fertility clinic.

Sources

Terms in this post

revns publishes training and nutrition guidance, not medical advice. See a clinician for symptoms, injury or a medical condition. Accurate as of November 17, 2026.

Questions

What is recurrent miscarriage?

Clinicians usually call it recurrent pregnancy loss (RPL). The Stanford Medicine release on this study defines it as two or more miscarriages and says it affects about 5% of couples. The NHS often starts specialist referral after three consecutive losses in the UK, though services differ. It is a medical term for a pattern of loss, not a judgment on you or your training.

What causes recurrent miscarriage?

Many causes are known, including chromosome problems in the embryo, uterine factors, blood-clotting disorders, endocrine disease and others still being studied. This 2026 Genome Medicine paper studied families whose losses had normal chromosome tests and usually normal early ultrasound — the "unexplained euploid" group. It found plausible single-gene variants in 30 of 118 families. That does not mean genes explain every case or that exercise caused the losses.

What did the 2026 genome sequencing study find?

Aminbeidokhti et al. sequenced parents plus miscarriage tissue in 118 families across five US academic centres. Pathogenic or likely pathogenic variants appeared in 18 families (15.3%). Variants of uncertain significance appeared in 12 more (10.2%). Stanford Medicine reports that in 24 of 30 families with plausible findings, at least one parent carried the variant, often without symptoms. The paper says variants in candidate genes were inherited in 80% of those families.

Does recurrent miscarriage mean I cannot exercise?

Not by itself. When you are medically cleared for activity and not in acute bleeding or pain, national pregnancy guidelines support regular moderate exercise for many people. After a loss, return to movement is personal: walking and gentle strength are common starting points once your clinician says it is safe. Heavy training while actively trying to conceive is a conversation for your GP or fertility team, not for an app.

Can genome testing prevent recurrent miscarriage?

Not yet as routine care. The authors say confirmed pathogenic variants could one day help counselling and might eventually support embryo testing in IVF, but variants of uncertain significance and newly proposed genes should not guide embryo selection or treatment until more evidence exists. The team is enrolling more families to confirm the genes. No home DNA kit replaces a genetics clinic.

When should I see a doctor after repeated miscarriages?

After one loss, many people need only routine follow-up. After two or more, or if you bleed heavily, have severe pain, fever or feel unwell, contact your GP or early pregnancy unit promptly. In the UK the NHS advises speaking to a GP after three consecutive miscarriages for referral; do not wait if symptoms worry you. If grief feels overwhelming or you have thoughts of harming yourself, seek urgent help from a clinician or a crisis line in your country — this article cannot replace that care.

Read next

Your first brief is one entry away.

Pick an objective, say how you eat, log one thing.